Analysis of Synthetic DNA
Applications | 2024 | ShimadzuInstrumentation
Synthetic oligonucleotides play a growing role in pharmaceuticals, diagnostics, and gene therapy. Reliable analytical methods are essential to confirm sequence integrity, assess purity, and detect process-related impurities. Reversed-phase liquid chromatography coupled with mass spectrometry (LC–MS) offers high sensitivity and specificity for oligonucleotide characterization, making it indispensable in quality control and research laboratories.
This application report demonstrates a streamlined LC–MS workflow using the Shim-pack Scepter™ Claris C18-120 column and LCMS-2050 system for the separation and detection of synthetic DNA oligonucleotides. The study aims to optimize chromatographic conditions, evaluate mass spectrometric parameters in negative ion mode, and illustrate the method’s suitability for routine analysis of oligonucleotide pharmaceuticals.
The analytical method combines high-efficiency reversed-phase chromatography with electrospray ionization mass spectrometry. Key conditions include:
The method achieved sharp, well-resolved peaks for target oligonucleotides within a 25-minute runtime. The ion-pairing reagents HFIP and TEA enhanced retention and peak shape. Mass spectra displayed clean deprotonated molecular ions with minimal adduct formation. System reproducibility and sensitivity were sufficient for low-picomole quantitation, supporting accurate identification and purity assessment.
Advances in ultra-high–pressure liquid chromatography and high-resolution mass spectrometry promise even faster, more detailed oligonucleotide profiling. Integration with automated sample handling and MS/MS fragmentation will enable deeper impurity characterization and sequence confirmation. Emerging ion-pair alternatives and microflow technologies may further reduce analysis time and solvent consumption.
This application demonstrates an effective LC–MS platform for synthetic DNA analysis, combining Shim-pack Scepter™ Claris C18 column efficiency with sensitive MS detection. The optimized method delivers rapid, reliable separation and characterization of oligonucleotides, meeting the demands of pharmaceutical development and quality control.
LC/MS, LC/SQ, Consumables, LC columns, HPLC
IndustriesPharma & Biopharma
ManufacturerShimadzu
Summary
Significance of the Topic
Synthetic oligonucleotides play a growing role in pharmaceuticals, diagnostics, and gene therapy. Reliable analytical methods are essential to confirm sequence integrity, assess purity, and detect process-related impurities. Reversed-phase liquid chromatography coupled with mass spectrometry (LC–MS) offers high sensitivity and specificity for oligonucleotide characterization, making it indispensable in quality control and research laboratories.
Objectives and Study Overview
This application report demonstrates a streamlined LC–MS workflow using the Shim-pack Scepter™ Claris C18-120 column and LCMS-2050 system for the separation and detection of synthetic DNA oligonucleotides. The study aims to optimize chromatographic conditions, evaluate mass spectrometric parameters in negative ion mode, and illustrate the method’s suitability for routine analysis of oligonucleotide pharmaceuticals.
Methodology and Instrumentation
The analytical method combines high-efficiency reversed-phase chromatography with electrospray ionization mass spectrometry. Key conditions include:
- Column: Shim-pack Scepter Claris C18-120 (100 mm × 2.1 mm, 1.9 µm particle size)
- Mobile Phases: A – 95.4 mM HFIP/7.1 mM TEA in water; B – same additives in methanol
- Gradient: 5% B initial, linear increase to 35% at 15 min, ramp to 80% at 16–17 min, return to 5% by 25 min
- Flow Rate: 0.3 mL/min; Column Temperature: 50 °C; Injection Volume: 2.33 µL (10 pmol)
- Detection: Photodiode array monitoring 200–400 nm; MS: ESI/APCI negative mode, m/z 600–2000
Main Results and Discussion
The method achieved sharp, well-resolved peaks for target oligonucleotides within a 25-minute runtime. The ion-pairing reagents HFIP and TEA enhanced retention and peak shape. Mass spectra displayed clean deprotonated molecular ions with minimal adduct formation. System reproducibility and sensitivity were sufficient for low-picomole quantitation, supporting accurate identification and purity assessment.
Benefits and Practical Applications
- High-resolution separation of closely related oligonucleotide sequences
- Robust detection in negative ion mode for improved signal-to-noise ratio
- Rapid method suitable for routine QC of therapeutic oligonucleotides
- Minimal sample preparation with direct injection of aqueous samples
Future Trends and Opportunities
Advances in ultra-high–pressure liquid chromatography and high-resolution mass spectrometry promise even faster, more detailed oligonucleotide profiling. Integration with automated sample handling and MS/MS fragmentation will enable deeper impurity characterization and sequence confirmation. Emerging ion-pair alternatives and microflow technologies may further reduce analysis time and solvent consumption.
Conclusion
This application demonstrates an effective LC–MS platform for synthetic DNA analysis, combining Shim-pack Scepter™ Claris C18 column efficiency with sensitive MS detection. The optimized method delivers rapid, reliable separation and characterization of oligonucleotides, meeting the demands of pharmaceutical development and quality control.
References
- Shimadzu Corporation. Application News 01-00662 (JP, ENG), 2024.
- Shim-pack Scepter Claris C18-120, Nexera™ XS inert, LCMS-2050 brochure, Shimadzu Corporation, First Edition: Sep. 2024.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Qualitative Analysis of Synthetic DNA Using a Single Quadrupole Mass Spectrometer
2023|Shimadzu|Applications
LCMS-2050 Liquid Chromatograph Mass Spectrometer Application News Qualitative Analysis of Synthetic DNA Using a Single Quadrupole Mass Spectrometer Junna Nakazono User Benefits Oligonucleotides can be easily analyzed using a Nexera™ XS inert UHPLC system and an LCMS-2050 single quadrupole…
Key words
oligonucleotide, oligonucleotidetherapeutics, therapeuticsscepter, scepterggtgtcaggctcacggaccactgcacaacaatcccacgacgtcgc, ggtgtcaggctcacggaccactgcacaacaatcccacgacgtcgcmolecular, molecularnakazono, nakazonojunna, junnaclaris, clarisinert, inertmargin, marginnews, newsattracted, attractedchromatogram, chromatogramquadrupole, quadrupolesynthesized
Analysis of Impurities in Oligonucleotide Therapeutics
2024|Shimadzu|Applications
ERAS-1000-0583 LC-MS Reversed-phase Shim-packTM Series Shim-pack ScepterTM Claris C18-300 Analysis of Impurities in Oligonucleotide Therapeutics 583 Keywords: Quality control, Purity confirmation, Bio inert coating column 1. FLP 2.n-1 (3') 3.n-3 (3') 4.n-10 (5') [HPLC conditions] (NexeraTM XS inert) Column Flow…
Key words
flow, flownexeratm, nexeratmgas, gaspacktm, packtmtherapeutics, therapeuticsdesolvation, desolvationoligonucleotide, oligonucleotidenebulizing, nebulizingshim, shimtemperature, temperatureinert, inertheating, heatingdrying, dryingreversed, reversedphases
Measurement of Oligonucleotide Impurities Using Shimadzu Nexera XS Inert Coupled To LCMS-9030 QTOF
2024|Shimadzu|Applications
Measurement of Oligonucleotide Impurities/ LCMS-9030 Application News Measurement of Oligonucleotide Impurities Using Shimadzu Nexera XS Inert Coupled To LCMS-9030 QTOF Shannie Tay1, Derrick Tan1, Celine Sim2 1 Shimadzu Asia Pacific, Singapore 2 Nanyang Technological University, Singapore User Benefits End-to-end…
Key words
std, stdbiologics, biologicsoligonucleotide, oligonucleotidelabsolutions, labsolutionsinsight, insightimpurities, impuritiessad, sadimpurity, impurityloss, losssge, sgescore, scorerepeatability, repeatabilitymean, meannews, newsdeviation
Efficient Method Development of Small Interfering RNA by Reversed-Phase Ion-Pair Chromatograph
2023|Shimadzu|Posters
Efficient Method Development of Small Interfering RNA by Reversed-Phase Ion-Pair Chromatography Daiki 1 Fujimura , Yusuke 1 Osaka 1Shimadzu , Corporation Chromatograms measured under the concentration of HFIP (100 and 200 mmol/L) are shown in Fig.5. The result shows that…
Key words
antisense, antisensescepter, scepterdipea, dipeamau, maushim, shimpack, packsence, sencemmol, mmolclaris, clarisstrand, strandline, lineimpurity, impurityshifted, shiftedoptimal, optimaldaiki